Free Trial
NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

$46.50 -1.11 (-2.33%)
Closing price 09/12/2025 04:10 PM Eastern
Extended Trading
$46.53 +0.03 (+0.07%)
As of 09/12/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Key Stats

Today's Range
$46.50
$47.43
50-Day Range
$41.06
$47.85
52-Week Range
$35.22
$48.76
Volume
106,828 shs
Average Volume
50,423 shs
Market Capitalization
$167.40 million
Assets Under Management
$169.94 million
Dividend Yield
1.27%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Pharmaceuticals ETF Expenses

TypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.35%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.35%0.60%0.63%0.58%0.60%
Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XPH ETF News Headlines

5 Biggest Pharmaceutical ETFs in 2025
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
XPH: Healthcare Dashboard For July
See More Headlines

XPH ETF - Frequently Asked Questions

SPDR S&P Pharmaceuticals ETF's stock was trading at $42.99 at the start of the year. Since then, XPH stock has increased by 8.2% and is now trading at $46.50.

SPDR S&P Pharmaceuticals ETF's top institutional investors include Bank of America Corp DE (18.35%), Kingsview Wealth Management LLC (6.58%), First Citizens Bank & Trust Co. (4.90%) and Envestnet Portfolio Solutions Inc. (4.47%).

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XPH
Inception Date
6/19/2006
Fund Manager
Michael Feehily, Karl Schneider, Keith Richardson

Fund Focus

Asset Class
Equity
Benchmark
S&P Pharmaceuticals Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
58

Fund Statistics

Assets Under Management
$169.94 million
Average Daily Volume
$73.63 thousand
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
37
Put Options
15
Call Options
22
Short Interest
1,050,000 shs

Miscellaneous

Beta
0.84
Creation Unit
50,000
Creation Fee
$250.00
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure


This page (NYSEARCA:XPH) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners